Assoc Prof, University of Patras, Greece
đ©ââïž Karolina-Anthoula Akinosoglou, born in Patra, Greece, on September 18, 1982, is a distinguished Associate Professor of Internal Medicine at the University of Patras. đ„ She obtained her medical degree from the University of Patras (2006) and completed her PhD at Imperial College London (2011) specializing in Immunogenomics and Infection. đ Her clinical expertise spans infectious diseases, internal medicine, and tropical medicine, serving as a consultant at the University Hospital of Patras and a private maternity clinic. âïž Dr. Akinosoglou has published extensively with over 149 peer-reviewed journal articles and boasts a remarkable h-index of 35. đïž She is a sought-after speaker at international conferences and an active member of several scientific societies. đ Dr. Akinosoglou is also involved in mentoring postgraduate students and leads various research projects in infectious diseases, precision medicine, and epidemiology. đ Her contributions have earned her numerous awards and recognition worldwide.
Profile
scopus
Education đ
Karolina-Anthoula Akinosoglou holds a Medical Degree (2000-2006) from the University of Patras and a PhD (2007-2011) from Imperial College London, where she specialized in Immunogenomics and Infection. đ She received postgraduate training at renowned institutions including St Markâs and Northwick Park Hospital in London. đ Her academic journey reflects a commitment to bridging clinical practice with innovative research. đ Beyond her degrees, Dr. Akinosoglou has continuously enriched her expertise through various certifications and fellowships, including Good Clinical Practice (GCP). đ She also leads educational programs in Precision Medicine, Epidemiology, Public Health, and Research Methodology at the University of Patras and the Hellenic Open University. đïž Her extensive teaching portfolio spans undergraduate, postgraduate, and resident programs, emphasizing clinical skills, tropical medicine, and infectious diseases. đ Dr. Akinosoglouâs educational background underpins her influential role in both clinical and academic medicine, shaping future healthcare leaders.
Experience đ„
Karolina-Anthoula Akinosoglou began her medical career in Infection and Tropical Medicine at St Markâs and Northwick Park Hospital (2008-2010). đ©ș She then joined the University Hospital of Patras (2010-today), advancing from Internal Medicine Resident to Associate Professor and Consultant in Infectious Diseases. đ She led the hospital’s COVID-19 ward and post-COVID clinic (2020-2022) and is currently an Infectious Diseases Consultant at a private maternity clinic. đ Dr. Akinosoglou has trained numerous residents and led postgraduate courses in Tropical Medicine, Respiratory Failure, and Clinical Epidemiology. đ§Ș She is also a Principal Investigator in multiple clinical trials and supervises doctoral and masterâs theses. đ Her involvement extends to university and hospital committees, focusing on ethics, quality assessment, and infection control. đ With over a decade of leadership in clinical care, research, and education, Dr. Akinosoglou is a pillar of modern Greek medicine.
Awards and Honors đ
Karolina-Anthoula Akinosoglou has been recognized with numerous prestigious awards for her contributions to medicine and research. âïž She received the Leventis Foundation Scholarship for postgraduate studies (2007-2010) and multiple Young Investigator Travel Awards from ISAC, ESCMID, and EACS. đ Her achievements include the Sotiris Papastamatis Prize for abstract merit (2017, 2022-2024) and scholarships for HIV Summer Schools and Infectious Diseases Fellow Programs. đïž In 2023, she won the 3rd Prize at the 20th European Shock Society Congress and was listed in Stanford/Elsevierâs Top 2% Scientists Rankings. đ Dr. Akinosoglouâs consistent excellence in research and clinical practice has earned her numerous travel grants and conference scholarships from leading organizations like Gilead, ASM, and ISHEID. đ„ Her accolades underline her dedication to advancing internal medicine and infectious diseases on both national and international levels.
Research Focus đŹ
Karolina-Anthoula Akinosoglou specializes in infectious diseases, internal medicine, and tropical medicine with a focus on HIV, HBV, HDV, HEV, and sepsis. đ§Ș She has led groundbreaking research in platelet activation, regulatory T-cells in HIV, and viral co-infections in Greece. đ Her work is supported by major grants from organizations like Gilead and the Hellenic Institute for Sepsis, with notable studies such as PRESS, Asklepios, and Karatheodoris projects. đ As a Principal Investigator and Sub-Investigator in over 30 multicenter clinical trials, she emphasizes precision medicine, epidemiology, and public health. đ Dr. Akinosoglouâs contributions include guideline development for the Hellenic Society of Infectious Diseases and obstetric infections. đ She actively publishes in top journals, focusing on antimicrobial resistance, sepsis, and emerging infections, making her a key figure in global infectious disease research. đ©ș Her innovative approach bridges clinical care and translational science.
Publications Top Notesđ
- Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trial
- Authors: Kyriazopoulou, E., Hasin-Brumshtein, Y., Midic, U., et al.
- Journal: Critical Care, 2024, 28(1), 73
- Citations: 4
- Overview: The article investigates immune changes in blood during COVID-19 pneumonia and examines how anakinra impacts clinical outcomes.
- qSOFA combined with suPAR for early risk detection and guidance of antibiotic treatment in the emergency department: a randomized controlled trial
- Authors: Adami, M.E., Kotsaki, A., Antonakos, N., et al.
- Journal: Critical Care, 2024, 28(1)
- Citations: 7
- Overview: This trial combines qSOFA scores and suPAR levels to assess early risk and guide antibiotic use in emergency settings.
- Global, regional, and national stillbirths at 20 weeks’ gestation or longer in 204 countries and territories, 1990â2021: findings from the Global Burden of Disease Study 2021
- Authors: Comfort, H., McHugh, T.A., Schumacher, A.E., et al.
- Journal: The Lancet, 2024, 404(10466), pp. 1955â1988
- Citations: 1
- Overview: The study presents a comprehensive analysis of stillbirth data globally over the past three decades, examining trends and disparities.
- Prolactin Role in COVID-19 and Its Association with the Underlying Inflammatory Response
- Authors: Polyzou, E., Schinas, G., Bountouris, P., et al.
- Journal: International Journal of Molecular Sciences, 2024, 25(22), 11905
- Citations: 0
- Overview: This article explores how prolactin levels in COVID-19 patients correlate with inflammatory responses and disease progression.
- Modulation of Metabolomic Profile in Sepsis According to the State of Immune Activation
- Authors: Kranidioti, E., Ricaño-Ponce, I., Antonakos, N., et al.
- Journal: Critical Care Medicine, 2024, 52(11), pp. e536âe544
- Citations: 0
- Overview: The study investigates how metabolomic profiles in sepsis are affected by immune activation status, providing insights into sepsis management.
- Antiviral therapy for patients with COVID-19: mix and match
- Authors: Akinosoglou, K., Gogos, C.
- Journal: The Lancet Infectious Diseases, 2024, 24(11), pp. 1179â1181
- Citations: 0
- Overview: This article reviews antiviral therapies for COVID-19, focusing on combination treatments to improve patient outcomes.
- Rapid Molecular Diagnostics in Vulvovaginal Candidosis
- Authors: Akinosoglou, K., Schinas, G., Papageorgiou, D., et al.
- Journal: Diagnostics, 2024, 14(20), 2313
- Citations: 0
- Overview: A review of the use of rapid molecular diagnostics in diagnosing vulvovaginal candidosis, aiming for faster and more accurate treatments.
- Mpox and Lessons Learned in the Light of the Recent Outbreak: A Narrative Review
- Authors: Protopapas, K., Dimopoulou, D., Kalesis, N., et al.
- Journal: Viruses, 2024, 16(10), 1620
- Citations: 0
- Overview: This review assesses the recent Mpox outbreak, drawing lessons to better manage future outbreaks.
- Treatment Management Challenges in NaĂŻve and Experienced HIV-1-Infected Individuals Carrying the M184V Mutation
- Authors: Mimtsoudis, I., Tsachouridou, O., Akinosoglou, K., et al.
- Journal: Viruses, 2024, 16(9), 1392
- Citations: 0
- Overview: The article discusses the challenges in treating HIV-1-infected patients, especially those with the M184V mutation, which affects drug resistance.
- Probiotics in the Management of Vulvovaginal Candidosis
- Authors: Akinosoglou, K., Schinas, G., Polyzou, E., et al.
- Journal: Journal of Clinical Medicine, 2024, 13(17), 5163
- Citations: 0
- Overview: This review examines the role of probiotics in treating vulvovaginal candidosis and its potential as an alternative or adjunct therapy.
Conclusion
Dr. Karolina-Anthoula Akinosoglouâs qualifications and contributions position her as an outstanding candidate for the Research for Best Researcher Award. Her combination of academic excellence, leadership in both clinical and academic settings, and high-impact research contributions in infectious diseases makes her a formidable force in the field of global healthcare. With minor improvements in interdisciplinary research and public engagement, she has the potential to amplify the impact of her work, making her highly deserving of this prestigious recognition.